Avascular Necrosis Market to Reach USD 1,129.1 Million by 2033 Driven by Rising Orthopedic Condition

ALBANY, N.Y. - July 2, 2025 - PRLog -- According to the latest report by Ameco Research, the global avascular necrosis market size was valued at USD 692.4 million in 2024 and is projected to reach USD 1,129.1 million by 2033, growing at a CAGR of 5.7% from 2025 to 2033. This upward trajectory is attributed to the growing burden of musculoskeletal disorders, increased healthcare awareness, and advancements in regenerative medicine and minimally invasive treatments.

What is Avascular Necrosis?

Avascular necrosis (AVN), also known as osteonecrosis, is a condition characterized by the loss of blood supply to bone tissue, leading to bone death and collapse. Most commonly affecting the hip, knee, shoulder, and ankle joints, the condition is driven by trauma, long-term steroid use, alcoholism, and underlying diseases like sickle cell anemia or lupus.

With an aging population and a global rise in orthopedic ailments, the demand for early diagnosis, preventive care, and effective treatment options for AVN is growing rapidly.

Key Market Drivers

• Rising Incidence of Orthopedic Disorders: Increased cases of joint trauma and arthritis contribute significantly to the rising demand for AVN treatment options.
• Technological Advancements: Innovative therapies such as stem cell treatments, bone graft substitutes, and 3D-printed implants are reshaping treatment standards.
• Minimally Invasive Procedures: Demand is shifting toward less invasive approaches like core decompression and percutaneous drilling that offer quicker recovery and improved outcomes.

Get Sample Pages of This Report (https://www.amecoresearch.com/sample/277152)

Avascular Necrosis Market Regional Insights

• North America held the largest share of the avascular necrosis market in 2023, thanks to a well-established healthcare infrastructure, advanced treatment facilities, and supportive reimbursement policies.
• The Asia-Pacific region is projected to witness the fastest growth rate, driven by a rising patient population, improved access to healthcare services, and increasing government investments in healthcare technology.

Competitive Landscape

Some of the prominent players in the global avascular necrosis market include:

• Zimmer Biomet
• Medtronic plc
• Stryker Corporation
• Smith & Nephew plc
• Johnson & Johnson
• Wright Medical Group N.V.
• Integra LifeSciences Corporation

Avascular Necrosis Market Future Outlook

As advancements in medical technologies continue to accelerate, the avascular necrosis market is poised for robust growth. Increasing clinical trials in gene and cell-based therapies, combined with enhanced diagnostics and personalized medicine, are expected to shape the future of AVN treatment.

📌 About the Report

The report titled "Avascular Necrosis Market – Global Industry Analysis, Forecast 2025–2033" offers a comprehensive analysis of current trends, market size, growth drivers, challenges, and competitive landscape.

To explore the full report, visit:

🔗 https://www.amecoresearch.com/market-report/avascular-necrosis-market-277152